Wilson Sonsini, in partnership with EY and Colorado BioScience Association, invites you to an in-depth program bringing together leaders, investors, and innovators from across Colorado’s life sciences ecosystem discussing our current funding environment.  

At the center of this program are the EY Biotech and Medtech Reports, cornerstone analyses that reveal the realities behind industry headlines. These reports will highlight surprising capital raises in a down market, impact of policy changes on funding, and the trends shaping biotech and medtech investment. Attendees will hear directly from EY experts as they present the latest data and insights, offering a clear-eyed perspective on the opportunities and risks facing today’s companies. 

Panel discussions moderated by Wilson Sonsini partner Brent Fassett and chief business advisor Matthew Meyer will dive deeper into these findings, exploring how entrepreneurs, investors, and executives can manage through a challenging venture capital environment, and find creative pathways to success. 

Through the combination of data-driven analysis and practical discussion, participants will leave with a sharper understanding of the biotech and medtech landscapes and actionable insights to guide strategy in 2026 and beyond.